Sterling Capital Management
TYRA icon

Sterling Capital Management’s Tyra Biosciences TYRA Stock Holding History

Sterling Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.6K Buy
1,217
+1,088
+843% +$29.9K ﹤0.01% 2049
2026
Q2 		$4.12K Sell
129
-729
-85% -$24.1K ﹤0.01% 2722
2026
Q1 		$32.9K Sell
858
-630
-42% -$20.4K ﹤0.01% 1809
2025
Q4 		$39.1K Sell
1,488
-174
-10% -$3.2K ﹤0.01% 1896
2025
Q3 		$23.3K Buy
1,662
+1,012
+156% +$11.5K ﹤0.01% 2077
2025
Q2 		$6.22K Buy
650
+629
+2,995% +$5.98K ﹤0.01% 2398
2025
Q1 		$195 Hold
21
– – ﹤0.01% 3087
2024
Q4 		$292 Hold
21
– – ﹤0.01% 3083
2024
Q3 		$494 Buy
+21
New +$441 ﹤0.01% 2876

Other funds holding TYRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Sterling Capital Management's TYRA Position: Q3 2026 in Review

Sterling Capital Management increased its Tyra Biosciences (TYRA) stake by 843% in Q3 2026, buying an estimated $29.9K and bringing the position to 1,217 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

Sterling Capital Management first reported a position in TYRA in Q3 2024 and has held it in 9 quarters since. The position peaked at $39.1K in Q4 2025. 75 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Sterling Capital Management held 1,217 shares of Tyra Biosciences worth $26.6K as of Q3 2026.
  • Sterling Capital Management bought 1,088 Tyra Biosciences shares in Q3 2026, an estimated $29.9K.
  • Tyra Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2049 holding.
  • Sterling Capital Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Tyra Biosciences position peaked at $39.1K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.